Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Abilify

ABILIFY 7.5 mg/mL solution for injection · Abschnitt 4.8 · PDF-Seite 69

HOS-217922 · Präparat HOS-216111

Vascular disorders Orthostatic Venous thromboembolism hypotension (including pulmonary embolism and deep vein thrombosis) Hypertension Syncope Respiratory, Hiccups Aspiration pneumonia thoracic and Laryngospasm mediastinal Oropharyngeal spasm disorders Gastrointestinal Constipation Mouth dry Pancreatitis disorders Dyspepsia Dysphagia Nausea Diarrhoea Salivary Abdominal discomfort hypersecretion Stomach discomfort Vomiting Hepatobiliary Hepatic failure disorders Hepatitis Jaundice Skin and Rash subcutaneous tissue Photosensitivity reaction disorders Alopecia Hyperhidrosis Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Musculoskeletal Rhabdomyolysis and connective Myalgia tissue disorders Stiffness Renal and urinary Urinary incontinence disorders Urinary retention Pregnancy, Drug withdrawal syndrome puerperium and neonatal (see section 4.6) perinatal conditions Reproductive Priapism system and breast disorders General disorders Fatigue Temperature regulation disorder and administration (e.g. hypothermia, pyrexia) site conditions Chest pain Peripheral oedema Investigations Diastolic blood Weight decreased pressure increased Weight gain Alanine Aminotransferase increased Aspartate Aminotransferase increased Gamma-glutamyltransferase increased Alkaline phosphatase increased QT prolonged Blood glucose increased Glycosylated haemoglobin increased Blood glucose fluctuation Creatine phosphokinase increased

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.